Related Experiment Videos
Nonpharmacologic therapy in heart failure: an overview
Pradeep S Arumugham1, Christopher M O'Connor
1Division of Cardiology, Department of Medicine, Box 3356, Duke University Medical Center, Durham, NC 27710, USA. arumu002@mc.duke.edu
Current Heart Failure Reports
|March 28, 2007
Summary
Despite advances in heart failure treatment, incidence and mortality remain high. Nonpharmacologic therapies, including surgical options, devices, and exercise, offer life-saving benefits for specific patient groups.
Area of Science:
- Cardiology
- Medical Therapy
- Heart Failure Management
Background:
- Heart failure (HF) therapies have evolved significantly.
- Despite therapeutic advancements, HF incidence and mortality rates continue to increase.
- Current pharmacological approaches address various pathophysiologic states.
Purpose of the Study:
- To review current evidence on nonpharmacologic therapies for heart failure.
- To explore future directions in nonpharmacologic heart failure treatment.
- To highlight the role of surgical options, devices, and exercise.
Main Methods:
- Literature review of existing studies on nonpharmacologic heart failure interventions.
- Analysis of current clinical evidence for surgical, device-based, and exercise therapies.
- Synthesis of data to identify trends and future research needs.
Main Results:
- Nonpharmacologic therapies are crucial for specific heart failure patient subsets.
- Surgical interventions, device therapies, and exercise programs demonstrate significant impact.
- Evidence supports the life-saving potential of these nonpharmacologic approaches.
Conclusions:
- Nonpharmacologic therapies are integral to comprehensive heart failure management.
- Further research and clinical application of these strategies are warranted.
- Optimizing nonpharmacologic interventions can improve outcomes in heart failure patients.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...